NCT05847751View on ClinicalTrials.gov

The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis

Active, not recruitingOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Severe Aortic Valve Stenosis
Interventions
DEVICE

Aortic valve replacement

Trans Aortic Valve Replacement (TAVI)

Trial Locations (7)

Unknown

Magdy Yacoub heart center, Aswān

Ain shams Specialized hospital, Cairo

Badr hospital, Cairo

American University of Beirut, Beirut

King Fahad Armed Forces Hospital, Jeddah

King Fahad National Guard Hospital, Riyadh

National Guard Hospital - King Abdulaziz Medical City, Riyadh

All Listed Sponsors
collaborator

European Cardiovascular Research Center

NETWORK

lead

Ceric Sàrl

INDUSTRY

NCT05847751 - The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis | Biotech Hunter | Biotech Hunter